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Abstract
Background
Currently there is limited research documenting the changes in blood parameters, following
Flexible Ureterorenoscopy. This study aims to determine whether there are any changes in
haematology and biochemistry parameters, following Flexible Ureterorenoscopy for the
treatment of kidney stones.
Methods
40 consecutive patients aged between 27–87 years (median 49 years) undergoing Flexible
Ureterorenoscopy for the treatment of kidney stones were recruited (26 male, 14 female).
Blood samples were collected from each patient at four time points: baseline (pre-opera-
tively) followed by 30 minutes, 120 minutes and 240 minutes post-operatively. On these
samples, routine haematological and biochemistry tests were carried out. In addition to the
assessment of clinical parameters prospectively from the medical notes.
Results
There was a significant decrease observed following Flexible Ureterorenoscopy in the fol-
lowing parameters: lymphocytes (p = 0.007), eosinophils (p = 0.001), basophils (p = 0.001),
haemoglobin (p = 0.002), red blood cells (p = 0.001), platelet count (p = 0.001), fibrinogen
concentration (p = 0.001), von Willebrand factor (p = 0.046), C reactive protein (p = 0.01),
total protein (p = 0.001), albumin (p = 0.001), globulin (p = 0.001) and alkaline phosphatase
(p = 0.001). In addition, there was a significant increase observed in the following parame-
ters: white blood cells (p = 0.001), neutrophils (p = 0.001), activated partial thromboplastin
time (p = 0.001), total bilirubin (p = 0.012), creatinine (p = 0.008), sodium (p = 0.002) and
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potassium (p = 0.001). Limiting factors for this study were the sample size, and restriction on
the recruitment time points.
Conclusions
Significant changes were noted to occur in haematology and biochemistry parameters fol-
lowing Flexible Ureterorenoscopy. Some of the data presented in this study may represent
the ‘normal’ post-operative response following FURS, as no major complications occurred,
in the majority of our patients. This data on the ‘normal response’ will need to be validated
but may ultimately aid clinicians in distinguishing patients at risk of complications, if repro-
duced in larger multi-centre studies.
Introduction
Kidney stones are increasing in prevalence and are recognised as a significant health issue [1],
affecting 2–3% of the worldwide population [2]. In 2015, there were 49 million cases of kidney
stones recorded, contributing to 15,000 deaths globally [3], [4]. Furthermore, it is predicted that
50% of patients who have had previous stones, will experience stone recurrence within 10 years
[5]. Recent epidemiological analysis has highlighted a 63% increase in the number of hospital
admissions in England, for kidney stones, during the past decade, with 86,742 cases reported in
2014–2015 alone [6]. Importantly, during this time there has been a 103% increase in the num-
ber of patients receiving ureteroscopic stone treatments since 2009/2010 [6]. This combination
of escalating incident rates, high stone recurrence rates and increasing use of minimally invasive
treatments, poses a considerable financial and economic burden for healthcare systems [7].
In the current European Association of Urology guidelines, Shock Wave Lithotripsy (SWL)
and Flexible Ureterorenoscopy (FURS) are considered equally suitable treatments for stones
between 11–20mm [8]. The Clinical Research Office of the Endourological Society (CROES)
study found that treatment of single intrarenal stones <10 mm in diameter with FURS,
resulted in a 90% successful stone free rate (SFR), and the SFR was 80% for stones as big as 15
mm [9]. As such, FURS has become the increasingly preferred treatment for kidney stones in
most cases.
The overall complication rate after FURS is 9–25% [10], with the CROES URS global study
identifying that bleeding, fever, Urinary Tract Infections (UTIs) and sepsis are common post-
operative complications following FURS. With increasing incidence, high recurrence rates
and annual increase in patients undergoing FURS, it is expected that the instances of such
complications will increase [11].
The aim of this study was to evaluate haematological and biochemistry changes in patients
undergoing FURS for the treatment of kidney stones. It was our expectation to enhance the
current urological literature by adding evidence based insight on this topic, and to provide
findings that may ultimately aid clinicians in distinguishing patients at risk of complications
such as bleeding or infection following FURS.
Materials and methods
Subject volunteers and FURS
Ethical approval for this pilot study was received from the Welsh Research Ethics Service
(REC) 4 committee (REC4: 12/WA/0117). Forty consecutive patients scheduled for elective
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FURS for the treatment of kidney stones were recruited at their pre-operative assessment after
providing written informed consent (n = 40). The patients (26 male and 14 females) were aged
between 27–87 years (median 49 years). Of the 40 patients, 27 had a single stone, 10 had two
stones and 3 patients had 3 stones in the target kidney. The median stone size was 7.0 mm
(range: 2.0 mm—25.0 mm). The median Hounsfield unit was 976 (range: 153–2224). The loca-
tion of the stones was upper pole (n = 15), mid-pole (n = 8) and lower pole (n = 17). Treatment
was given as per standardised protocol in our institution using the Olympus P5 Flexible Ure-
terorenoscope whilst under general anaesthesia using Propofol, with 75% (30/40) of the
patients receiving laser lithotripsy during the procedure for a median duration of 14.58 min-
utes (range: 30 seconds– 54.02 minutes), at an average energy of 3232.7 J, and a mean pulse of
6272.76. The median operative time for the FURS procedure was 49 minutes (range: 22–104
minutes). Complete stone clearance was achieved in all patients (n = 40) with 25/40 of the
patients requiring post-operative stent insertion. Stone samples for biochemical analysis were
collected where possible, and the composition was analysed using infrared spectroscopy at the
Leicester Royal Infirmary.
Blood samples
On the day of their intervention, each patient had a venous blood sample collected from the
arm, prior to the FURS procedure, which stood as a baseline (control) measurement. Following
FURS, additional blood samples were collected at 30, 120 and 240 minutes post-operatively.
Three vacutainers of blood were collected at each interval (di-potassium ethylene diamine tetra-
aceticacid (EDTA), tri-sodium citrate and serum separator tube). All haematological and bio-
chemical analysis was carried out on the day of the procedure on fresh whole blood/plasma,
with exception of vWF analysis which was carried out in batches every 6 months on frozen
patient plasma, stored at -80˚C, in accordance to the manufacturers protocol. Subject plasma
was obtained by centrifuging whole blood samples at 450g for 15 minutes.
Measurement of full blood count and platelet concentration
Complete blood counts were performed using a Sysmex XE-5000 automated cell counter and
platelets measured in units x109/L.
Measurement of activated partial thromboplastin time (aPTT),
prothrombin time (PT), fibrinogen and von willebrand factor (vWF)
aPTT (seconds), PT (seconds) and Fibrinogen (g/L) concentrations were measured using
citrated samples using the Sysmex CS2100 analyser. Plasma vWF concentrations (IU/dL) were
measured in the frozen samples, using a two-step sandwich method, enzyme immunoassay
(ELISA) using rabbit anti-human vWF and rabbit anti-human vWF peroxidase conjugate.
Measurement of plasma viscosity (PV)
Plasma viscosity (mPa/second) was measured using a Benson BV200 viscometer.
Measurement of biochemistry parameters
Biochemistry parameters were measured using the Beckman Coulter AU5800 and AU680
analyser.
Haematological and biochemical changes following Flexible Ureterorenoscopy for kidney stones
PLOS ONE | https://doi.org/10.1371/journal.pone.0179599 July 6, 2017 3 / 11
Statistical analysis
All results were presented as mean ± standard error (SE) or median ± min/max. Where data
was normally distributed, repeated measures one-way analysis of variance (ANOVA) between
samples test was employed, adopting a 5% level of significance. Post hoc testing was conducted
using the Bonferroni test for pairwise comparisons between means. Data that did not comply
with normality was analysed using the Friedman test. Where the Friedman test resulted in sta-
tistical significance, subsequent tests were performed using the Wilcoxon test. Statistical signif-
icance was accepted when p 0.05.
Results
Haematological blood results
“Fig 1” demonstrates the changes in haematological parameters observed following FURS for
the treatment of kidney stones (n = 40). Significant decreases were observed post FURS in the
following parameters: lymphocytes (p = 0.007), eosinophils (p = 0.001), basophils (p = 0.001),
haemoglobin (p = 0.002), red blood cells (p = 0.001), platelet count (p = 0.001) and fibrinogen
concentration (p = 0.001). In addition, significant increases were observed in white blood cell
(WBC) (p = 0.001) neutrophil (p = 0.001) concentrations and activated partial thromboplastin
time (p = 0.001). Non-significant changes were observed in monocyte, mean corpuscular hae-
moglobin, mean cell volume, red cell distribution width, packed cell volume, mean corpuscu-
lar haemoglobin concentration, plasma viscosity and prothrombin time values (p>0.05).
Biochemistry blood results
“Fig 2” demonstrates the changes in biochemistry parameters observed following FURS for the
treatment of kidney stones (n = 40). Significant decreases were observed post FURS in the
Fig 1. The effect of FURS, for the treatment of kidney stones on haematology parameters (n = 40).
Data analysed via Friedman testing is presented as median ±minimum / maximum, data analysed via
ANOVA is presented as means ± standard error. Statistical significance following post hoc analysis is
represented when*p0.05. (M = male, F = female).
https://doi.org/10.1371/journal.pone.0179599.g001
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following parameters: C reactive protein (p = 0.01), total protein (p = 0.001), albumin (p = 0.001),
globulin (p = 0.001) and alkaline phosphatase (p = 0.001) and von Willebrand factor (p = 0.046).
Whereas significant increases were observed post FURS in the following parameters: total biliru-
bin (p = 0.012), creatinine (p = 0.008), sodium (p = 0.002) and potassium (p = 0.001). Non-signif-
icant changes were observed in estimated glomerular filtration rate, alkaline phosphatase or urea
levels (p>0.05)
Post-operative complications
One female (participant 12) and two males (participants 9 and 10) developed a post-operative
UTI, and participant 32 (male) developed urosepsis. “Figs 1–4” show the average results of the
research population (n = 40) compared to the results from participant 9, 10, 12 and 32.
“Fig 3” shows the changes in WBC concentrations for participants 9, 10, 12 and 32 against
the average group response (n = 40). Participant 12 and 32 had significantly raised WBC
Fig 2. The effect of FURS, for the treatment of kidney stones on biochemistry parameters (n = 40).
Data analysed via Friedman testing is presented as median ±minimum / maximum, data analysed via
ANOVA analysis is presented as means ± standard error. Statistical significance following post hoc analysis is
represented when*p0.05. (M = male, F = female).
https://doi.org/10.1371/journal.pone.0179599.g002
Fig 3. Changes to white blood cell concentrations following FURS for the treatment of kidney stone
(s). Participants 9, 10, 12 and 32 who went onto develop post-operative complications compared to the
average group response (n = 40). Participant 9, 12 and 32 exhibit clinically significant changes that fall outside
of the normal reference range (4.0–11.0 x109/L).
https://doi.org/10.1371/journal.pone.0179599.g003
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counts, that increased in concentration post FURS. Furthermore, at the 240 minute interval,
participant 9 shows a marked increase in WBC concentration. “Fig 4” represents the changes in
neutrophil concentrations following FURS for participants 9, 10, 12 and 32 against the average
group response (n = 40). Participant 12 and 32 exhibit high baseline neutrophil concentrations,
which rise post-operatively and peak at 240 minutes post FURS. “Fig 5” shows changes in CRP
levels for participants 9, 10, 12 and 32 against the average group response (n = 40). Participant
10, 12 and 32 had CRP levels higher than the reference range at baseline, which escalated post
FURS. “Fig 6” shows the changes in creatinine levels post FURS for participants 9, 10, 12 and 32
against the average group response. Participant 12 and 32 had significantly higher creatinine
levels than the average group response, falling above the upper reference range limit “Fig 6”.
Stone analysis results
Stone samples were collected during the FURS procedure from 27 participants. Post-operative
calculus analysis found that 21 participants had Whewellite (CaC204.H20 -calcium oxalate
Fig 4. Changes to neutrophil concentrations following FURS for the treatment of kidney stone(s).
Participants 9, 10, 12 and 32 who went onto develop post-operative complications compared to the average
group response (n = 40). Participant 9,12 and 32 exhibit clinically significant changes that fall outside of the
normal reference range (1.7–7.5 x109/L).
https://doi.org/10.1371/journal.pone.0179599.g004
Fig 5. Changes to C reactive protein concentrations following FURS for the treatment of kidney stone
(s). Participants 9, 10, 12 and 32 who went onto develop post-operative complications compared to the
average group response (n = 40). Participant 10, 12 and 32 exhibit clinically significant changes that fall
outside of the normal reference range (0–5 mg/L).
https://doi.org/10.1371/journal.pone.0179599.g005
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monohydrate) stones, 8 had Apatite (Ca10(PO4)6-(OH)2—calcium phosphate) stones, 4 had
Cystine stones [SCH2CH(NH2)COOH]2, 4 had Carbonite apatite (Ca5(PO3)3(OH) -calcium
hydroxyl phosphate) stones and 3 had Wheddelite (CaC2O4.2H20—calcium oxalate dihydrate)
stones.
Discussion
The aim of this pilot-study was to investigate changes to haematological and biochemical
parameters following FURS, for the treatment of kidney stones. As such, we have shown that
significant changes in several haematological and biochemical biomarkers do occur.
Bleeding is a common feature following FURS, with haematuria being the most obvious
manifestation. Haematuria is generally present in patients as a consequence of stone disinte-
gration, resulting in minor lesions to the mucosa and irritation of the urothelium and damage
to blood vessels and the surrounding renal anatomy [12]. Episodes of tissue trauma are linked
to renal vascular damage resulting from contusion and small bleeding events, which are often
localised to the renal papilla. A review by Cornu, Herrmann, Traxer and Matlaga (2016) state
that the complications following endoscopic surgery are numerous, yet poorly understood due
to the lack of standardisation of reporting [13]. Our results show significant changes to several
parameters, including: bilirubin, albumin, aPTT, fibrinogen, platelet and RBC count which are
likely to be indicative of bleeding events.
Bilirubin is a yellow pigment formed in the liver by the breakdown of haemoglobin, and its
levels reflect the proportion of red blood cell haemolysis [14]. Therefore, the raised total biliru-
bin levels combined with the decrease in RBC counts observed in this study coincide with a
haematologic decline; possibly explaining the episodes of bleeding that are seen in some partic-
ipants [15]. Additionally, decreases in albumin levels, as seen in our study, may also lead to an
increased risk of bleeding, as albumin functions to prevent fluid from leaking out of blood
vessels.
Although we have previously reported on post-operative changes in haematological mark-
ers following various surgical procedures [16], [17] there is little evidence investigating the
direct effect of FURS on haematological and biochemistry parameters. The findings from our
2015 paper evaluating haemostatic function following extracorporeal shock wave lithotripsy
Fig 6. Changes to creatinine concentrations following FURS for the treatment of kidney stone(s).
Participants 9, 10, 12 and 32 who went onto develop post-operative complications compared to the average
group response (n = 40). Participant 9, 10, 12 and 32 exhibit clinically significant changes that fall outside of
the normal reference range (male: 58–110 Mmol/L (participants 9, 10, 32), female: 46–92 Mmol/L (participant
12).
https://doi.org/10.1371/journal.pone.0179599.g006
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(ESWL) highlighted significant changes to fibrinogen and vWF concentrations following
ESWL. As ESWL is a non-invasive procedure carried out with neither local nor general anaes-
thesia, the observed outcomes we previously documented are directly relatable to the proce-
dure. It is envisaged that similar trends will be seen in patients undergoing FURS for the
treatment of kidney stones, however it must be acknowledged that patients undergoing general
anaesthesia as routine for the FURS intervention may exhibit some contributory systemic
changes due to the physiological response to surgical stress or the pharmacological effects of
Propofol.
The effects of anaesthesia on hemodynamic changes in patients undergoing laparoscopic vs
open cholecystectomy has recently been reported by Samhan et al, (2016). Although they do
not comment on routine haematological or biochemistry based parameters, their findings do
report on changes seen in norepinephrine, epinephrine and cortisol; which all increase during
surgery and may have an effect on haemostasis [18]. Increases in these hormone levels during
surgery may have an effect on routine blood parameters. Further exploration into the effect of
systemic stress following FURS may prove beneficial; with the work by Aghamir et, al (2008)
evaluating inflammatory markers, concluding that changes to patients inflammatory responses
can be a useful indicator for assessing post-operative complications [19]. In our study, there
were significant decreases noted in fibrinogen levels at 30 and 240 minutes post-operatively
(P = 0.002). It is known that during clot formation, soluble fibrinogen is converted to insoluble
fibrin, which crosslinks together to stabilise clots at the site of injury. Previous studies have
demonstrated that decreases in fibrinogen concentrations following cardiac surgery correlate
to the amount of postoperative bleeding [20], [21]. Therefore, decreasing fibrinogen levels,
coupled with the findings of prolonged aPTT times, in our study, may provide evidence to sug-
gest that the participants in this cohort undergoing FURS may have a reduced ability to form a
stable blood clot. However, as fibrinogen is a non-specific acute phase reactant, it needs to be
assessed alongside other markers (ie. platelets). The results of this study show a significant
decrease in platelet counts (p = 0.001) up to 2 hours post FURS, which correlate with the
decrease in fibrinogen and prolonged aPTT. A likely explanation for the decrease in platelets
circulating in the peripheral blood is due to redistribution to the site of trauma, where they
aggregate onto the endothelium and vascular muscle lining [17]; or due to the effects of Propo-
fol, which has been documented to have inhibitory effects on platelet aggregation in patients
under general anaesthesia [22]. Similar findings were reported by Khafagy et al (2010), who
observed significant post-operative changes in platelet, PT and PTT in patients undergoing
general anaesthesia [23]. A decrease in vWF levels were seen post treatment in this study. Usu-
ally, one of the physiological applications of vWF is the tethering of platelets to damaged endo-
thelial sites [24]. However, as the FURS procedure is known to cause disturbances to the
normal vascular integrity, causing ureteric / renal trauma and in some instances mucosal
ischaemia [25], it is thought that the release of vWF from storage organelles in the vascular
endothelium may have been inhibited, therefore causing a reduction in vWF concentrations
post-operatively, as seen in this study.
Leukocytes play an integral role during an inflammatory response [26]. A decrease in neu-
trophil concentration is recorded in this study and this may be due to the demargination and
relocation of cells to the site of injury. Leukocyte demargination is known to stimulate the
endothelium, resulting in the release of signalling molecules from pro-inflammatory cytokines,
assisting the recruitment of additional leukocytes. This is also likely to explain the later
increase in neutrophil levels seen at 120 and 240 minutes post FURS, as well as the significant
changes to lymphocyte, eosinophil, and basophils that are seen in this study “Fig 1”. The results
from Aghamir et al (2008) paper also reported post-operative increases (24 hours) in leukocyte
Haematological and biochemical changes following Flexible Ureterorenoscopy for kidney stones
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concentrations, linking low- grade fever as a likely cause, which may be a contributory factor
in our patient population.
One of the participants in our study who developed a post-operative infection (Participant
9), interestingly had a ‘normal’ CRP level “Fig 5”, despite CRP being clinically recognised as a
marker of inflammation. As such, it may be inferred, that CRP may not always be a sensitive
enough marker to detect participants as risk of developing post-operative infections, following
FURS. This may be due to the nonspecific nature of CRP. Therefore, measurement of alterna-
tive markers of inflammation such as creatinine may be beneficial, as creatinine levels are regu-
lated by the kidneys, and may provide a more relevant indicator for localised inflammation. In
this study, clinically raised levels of creatinine were seen in participant 12 and 32. Overall it
can be appreciated that further detailed investigations into the inflammatory process and kid-
ney function post FURS is needed, as recent evidence links prolonged inflammation to scaring,
which in combination with oxidative stress, contributes to the pathogenesis of diabetes melli-
tus, hypertension and diabetic nephropathy [27]. Work by Uğuz S et al, (2016) explored the
effect on ozone therapy in reducing lithotripsy induced renal injury on rats during SWL and
found that administering ozone resulted in significant changes to biochemical results, notably
a reduction is AST and ALP, as well as ameliorating nitro-oxide stress [28]. Therefore, future
monitoring for sustained inflammation combined with the potential for therapeutic interven-
tion such as ozone therapy may lead to better patient outcomes.
To date there are very few reports on the effect of FURS, for the treatment of kidney stones,
on haematology and biochemistry parameters in human subjects. We therefore believe that
the results from this study are a welcome addition to the urological literature. However, in
order to fully understand the changes within the peripheral circulatory system, further studies
involving larger cohorts and longer post-operative monitoring and blood sampling (eg.
24hours +) is needed. The lack of a control arm in this study due to ethical restrictions is also
recognised as a limitation, baseline measurements were implemented to overcome this, how-
ever sampling procedures my need some revision in future to overcome the potential effects of
sampling pre-operatively whilst patients are in a non-physiological state and to fully under-
stand the attributing effects of anaesthesia on patients’ blood parameters.
Furthermore, it is acknowledged that a limiting factor of this pilot-study is the relatively
small number of participants recruited (n = 40). Nevertheless, we feel that these initial results
provide encouragement for further exploration into the inflammatory and phagocytic leuko-
cyte reactions and its correlation with clinical outcome measures (e.g. bleeding and infection),
in larger cohorts following FURS. Ultimately, if changes to haematology and biochemistry
markers following FURS can identify or predict those patients at increased risk, future direc-
tions of this study may offer the potential to guide practice, with the introduction of point of
care testing to predict those patients at risk of complications allowing for ‘pre-emptive’ inter-
ventions to be implemented; such as pharmacological intervention using anti-inflammatory or
anti-haemorrhagic agents to improve patient outcome, in those ‘at risk’ undergoing FURS for
kidney stones.
Conclusions
In conclusion, in this study we have shown several changes to haematology and biochemistry
parameters following FURS. Informed examination of these parameters, in the future, could
provide valuable data to aid clinicians in distinguishing a ‘normal’ response after FURS to
those that are ‘abnormal’. The ultimate goal is to be able to predict those patients at risk of
complications, such as bleeding or infection following FURS. The validation and reliability
needs to be assessed through larger cohort studies.
Haematological and biochemical changes following Flexible Ureterorenoscopy for kidney stones
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